Superluminal Medicines
Cambridge, United States· Est.
Superluminal Medicines is a biotechnology company creating small molecule drugs targeting G protein-coupled receptors for various diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $153M
About
Superluminal Medicines is a biotechnology company creating small molecule drugs targeting G protein-coupled receptors for various diseases.
Small MoleculesNeuroscience
Funding History
2Total raised:$153M
Series A$120M
PIPE$33M